Facet browsing currently unavailable
Page 1 of 1 results
Sort by: relevance publication year
Showing DOI matching
10.1056/NEJMoa1809697
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC JOURNAL ARTICLE published 13 December 2018 in New England Journal of Medicine |